title: Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.
authors.affiliation: Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Vella
authors.forename: C
authors.initials: C
authors.lastname: Galluzzo
authors.forename: G
authors.initials: G
authors.lastname: Giannini
authors.forename: M F
authors.initials: MF
authors.lastname: Pirillo
authors.forename: I
authors.initials: I
authors.lastname: Duncan
authors.forename: H
authors.initials: H
authors.lastname: Jacobsen
authors.forename: M
authors.initials: M
authors.lastname: Andreoni
authors.forename: L
authors.initials: L
authors.lastname: Sarmati
authors.forename: L
authors.initials: L
authors.lastname: Ercoli
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D004311:Double-Blind Method; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007546:Isoquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D011804:Quinolines / Q000009:adverse effects / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D019258:Saquinavir; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011804:Quinolines; D012367:RNA, Viral; D015215:Zidovudine; D019258:Saquinavir